NCT06878521

Brief Summary

The goal of this clinical trial is to determine the initial efficacy of an emotional regulation skills training (ERST) intervention program in a group of adolescents presenting mild symptoms affecting their ability to regulate emotions. For this purpose, a sample of 1st and 2nd-year high school students (ages 14-16) will be recruited, and the intervention will be conducted on the educational institution's premises during school hours. The main questions it aims to answer are: Does the ERST intervention reduce symptom levels in adolescents with mild emotional dysregulation? Does the ERST intervention improve emotional regulation skills in adolescents? Researchers will compare pre-intervention (T1) and post-intervention (T2) outcomes, as well as follow-up assessments at 3 months, to evaluate changes in symptom levels and emotional dysregulation. Additionally, a blinded teacher assessment will be conducted at T1 and T2 to evaluate symptom levels. Participants will: Attend the ERST intervention sessions during school hours. Complete self-report assessments at four time points (T1, T2, and 3-month follow-up). Be evaluated by a blinded teacher at T1 and T2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 12, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 17, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2025

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.4 years

First QC Date

January 29, 2025

Last Update Submit

March 10, 2026

Conditions

Keywords

AdolescentsEmotional regulationTransdiagnosticTransdiagnostic interventionGroup interventionEmotion Regulation Skills TrainingSchool-based intervention

Outcome Measures

Primary Outcomes (4)

  • Change from Baseline in Emotional Dysregulation Over Time Compared to the Control Group

    Emotional dysregulation is measured using the "Difficulty in Emotion Regulation Scale" (DERS-E). This self-report questionnaire is administered to participants at baseline (Day 0), at the end of the intervention (Month 2), and three months later for follow-up (Month 3).

    Day 0 = during enrollment, Month 2 = immediately after the experimental group completes the intervention, and Month 3 = three months later for follow-up

  • Change from Baseline in Psychological Functioning screening Over Time Compared to the Control Group

    Psychological functioning screening is assessed using the "Strengths and Difficulties Questionnaire" (SDQ) (self-report version), which measures emotional and behavioral difficulties. The minimum value for the general difficulty scale is 0, and the maximum value is 40, where higher scores indicate worse psychological functioning. This questionnaire is administered to participants at baseline (Day 0), at the end of the intervention (Month 2), and three months later for follow-up (Month 3).

    Day 0 = during enrollment, Month 2 = immediately after the experimental group completes the intervention, and Month 3 = three months later for follow-up

  • Change from Baseline in Anxiety Symptoms Over Time Compared to the Control Group

    Anxiety Symptoms are assessed using the "Generalized Anxiety Disorder 7" (GAD-7), which measures the presence and severity of anxiety symptoms. The minimum value for the scale is 0, and the maximum value is 21, where higher scores indicate worse anxiety symptoms. This questionnaires is administered to participants at baseline (Day 0), at the end of the intervention (Month 2), and three months later for follow-up (Month 3).

    Day 0 = during enrollment, Month 2 = immediately after the experimental group completes the intervention, and Month 3 = three months later for follow-up

  • Change from Baseline in Depressive Symptoms Over Time Compared to the Control Group

    The evaluates the severity of depressive symptoms. Depressive Symptoms are assessed using the "Patient Health Questionnaire 9" (PHQ-9), which measures the severity of depressive symptoms. The minimum value for the scale is 0, and the maximum value is 27, where higher scores indicate worse depressive symptoms. This questionnaires is administered to participants at baseline (Day 0), at the end of the intervention (Month 2), and three months later for follow-up (Month 3).

    Day 0 = during enrollment, Month 2 = immediately after the experimental group completes the intervention, and Month 3 = three months later for follow-up

Secondary Outcomes (1)

  • Change from Baseline in Clinical Symptoms Over Time Compared to the Control Group, with Masking in the Evaluation Process

    Day 0 = during enrollment, Month 2 = immediately after the experimental group completes the intervention

Study Arms (2)

Emotional regulation skills training Group

EXPERIMENTAL

Participants in this group will receive the emotional regulation skills training (ERST) intervention.

Other: Emotional Regulation Skills

Waitlist Control Group

NO INTERVENTION

Participants in this group will not receive the intervention initially and will be placed on a waitlist. They will receive the same emotional regulation skills training (ERST) intervention after the experimental group has completed the program.

Interventions

This intervention is inspired by and incorporates elements of Dialectical Behavior Therapy (DBT). It consists of eight weekly group sessions, each lasting approximately 1.5 to 2 hours, held on school premises. Each group includes 8 to 10 adolescents. The sessions are facilitated by two psychologists and/or senior psychology students who have been specifically trained to deliver the intervention. The sessions focus on developing various emotional regulation skills, which participants are encouraged to practice both during and between sessions. Some of the key skills covered include Mindfulness, Wise Mind, and Problem-Solving, among others.

Emotional regulation skills training Group

Eligibility Criteria

Age14 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Adolescents in their first or second year of high school.
  • Must be currently enrolled in school.
  • They should be referred for emotional dysregulation issues and require mental health support.
  • They must score above the 75th percentile on the total scale of the SDQ screening tool

You may not qualify if:

  • Adolescents who are regularly receiving psychological treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de La Frontera

Temuco, Chile

Location

MeSH Terms

Conditions

Emotional Regulation

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a randomized controlled trial (RCT) with a parallel-group design and a waitlist control group. Participants will be randomly assigned to one of two groups: 1. Experimental Group: This group will receive the emotional regulation skills training (ERST) intervention immediately. 2. Control Group: This group will not receive the intervention initially but will be placed on a waitlist and receive the same ERST intervention after the experimental group has completed the program. This design allows for a direct comparison between the experimental and control groups during the initial intervention period, ensuring that any observed effects can be attributed to the ERST program. The waitlist control group ensures that all participants eventually receive the intervention, maintaining ethical standards.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 29, 2025

First Posted

March 17, 2025

Study Start

July 12, 2024

Primary Completion

December 9, 2025

Study Completion

December 9, 2025

Last Updated

March 12, 2026

Record last verified: 2026-03

Locations